Big News: Kit Check Partners with Omnicell to offer BCS

Big News: Kit Check Partners with Omnicell to offer BCS
We are very excited to announce that we have entered into an agreement with Omnicell …

Omnicell and Kit Check Partner to Offer Cloud-based Solution for Tracking of Controlled Substances
Medication intelligence software solution supports critical need for hospitals and health systems to identify drug …

Bluesight for Controlled Substances featured in Quartz article about the role of tech in combating the opioid crisis
The nation is in the grip of a tragic opioid crisis, and drugs that are …
Kit Check’s Agreement with Vizient Extended in Multi-Year Contract, Providing Better Visibility in Drug Diversion and Medication Tracking
WASHINGTON (October 3, 2019) — Kit Check, the leader in automated medication management solutions for …
Kit Check’s Bluesight for Controlled Substances™ Recognized by KLAS as Leading Emerging Solution for Drug Diversion Monitoring
Bluesight for Controlled Substances heralded in industry report, earns rating of 93.2 out of 100 …

Bluesight for Controlled Substances Takes Top Score for Emerging Solutions in New KLAS Report
Leading healthcare IT analyst firm KLAS today published its inaugural drug diversion monitoring solution report. …

New Bluesight for Controlled Substances Feature: Investigation Portfolios
We are excited to announce the launch of our newest feature for the Bluesight for …
Kit Check Announces the Latest Bluesight for Controlled Substances Feature, Investigation Portfolios
Workflow collaboration tool helps hospitals locate possible diverters with accuracy Washington DC, June 25, 2019 …

The Data Science Behind Drug Diversion Detection with Bluesight for Controlled Substances
Data science has emerged as an ally for hospital directors of pharmacy in the continuous …

50 Hospitals Adopt Bluesight for Controlled Substances to Reconcile Discrepancies Faster, Implement 100% Audit and Close the Diversion Gap
Kit Check introduced Bluesight for Controlled Substances (BCS) in 2017 at ASHP Midyear. At the …